In September 2007, AngioDynamics and PhotoMedex entered into a three-year OEM agreement under which PhotoMedex manufactures for AngioDynamics, on a non-exclusive basis, a private-label, 980-nanometer diode laser system.
The private placement will consist of 1.72 million shares at a price of $0.58. The closing of this transaction will bring Mr Laurin’s direct and indirect ownership position
Merck has said that the recall was issued because it can not assure sterility of these specific vaccine lots. The potential contamination of these specific lots was identified
The acquisition is subject to Abviva’s due diligence, final approval by Abviva’s board of directors and entry of an order approving the sale by the court. Genesis Bioventures
The Phase III study evaluated the efficacy of iloperidone versus placebo in patients with schizophrenia. The study was a randomized, double-blind, placebo-controlled, multi-center, four-week inpatient study that enrolled
Zimmer said that a key strength of its mobile bearing system is its ability to be used in a minimally invasive procedure – the LPS-Flex mobile knee is
The new products, to be marketed under the brand name CellPrime, will be manufactured by Novozymes and sold through Millipore’s sales organization. The alliance expands the existing relationship
With a target of 56 patients, the five sites participating in the trial have now enrolled 59 patients. The company said that given the small patient numbers in
Copernicus has earned the milestone payment by demonstrating a significant improvement in the level of CFTR gene activity in an animal model. This increased improvement in the level
The product is under development for the prevention of hepatitis C virus (HCV) re-infection after liver transplantation. As an outcome of its E1 research program, Genimmune has identified
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.